182 related articles for article (PubMed ID: 8088323)
1. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
5. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
Guidos C; Sinha AA; Lee KC
Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
[TBL] [Abstract][Full Text] [Related]
6. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
7. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
[TBL] [Abstract][Full Text] [Related]
9. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
10. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
[TBL] [Abstract][Full Text] [Related]
11. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
12. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the functions of antigen-presenting cells in the induction of T cell activation.
Roska AK; Lipsky PE
J Immunol; 1985 Nov; 135(5):2953-61. PubMed ID: 3876370
[TBL] [Abstract][Full Text] [Related]
14. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
15. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
16. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
Stockinger B
Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
[TBL] [Abstract][Full Text] [Related]
18. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
Grant CF; Ali R; Povey S; Stockinger B
Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
[TBL] [Abstract][Full Text] [Related]
19. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
20. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]